Steve Duffy

Most Recent Articles by Steve Duffy

CGRP Antagonist Shows Effectiveness in Acute Migraine

CGRP Antagonist Shows Effectiveness in Acute Migraine

By

Allergan has announced positive Phase 3 trial results for ubrogepant, a novel calcitonin gene-related peptide receptor antagonist for the acute treatment of migraine.

Evaluating Excessive NSAID Use in Ibuprofen Users

Evaluating Excessive NSAID Use in Ibuprofen Users

By

Fifteen percent of adults who took ibuprofen during a 1-week diary study exceeded the maximum recommended daily dose limit.

FDA Approves GammaCore Treatment for Migraine Pain

FDA Approves GammaCore Treatment for Migraine Pain

By

The FDA has granted GammaCore expanded clearance by the FDA to treat pain associated with migraine.

New Guidelines for Opioid Use in Refractory Restless Leg Syndrome

New Guidelines for Opioid Use in Refractory Restless Leg Syndrome

By

Opioids may be "life-transforming" for patients with refractory restless legs syndrome when taken in relatively low total daily doses, according to new guidelines.

Eptinezumab Effectively Reduces Migraine Frequency in Phase 3 Trial

Eptinezumab Effectively Reduces Migraine Frequency in Phase 3 Trial

By

Eptinezumab, an investigational treatment for migraine prevention, has met its pivotal Phase 3 trial primary endpoint of significant reduction in monthly migraine days vs placebo.

More Articles by Steve Duffy

Sign Up for Free e-Newsletters